This inventor holds 3 USPTO granted patents. Top assignee: The Green Cross Corporation. Active years: 1996-1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996-1999
Title: The Innovations of Minori Okita
Introduction
Minori Okita is an accomplished inventor based in Hirakata, Japan, renowned for her contributions in the field of circulatory disorder treatment. With a total of three patents to her name, she has made significant strides in improving healthcare outcomes through innovative formulations.
Latest Patents
Among her latest patents, Okita has developed a circulatory disorder improving agent that includes a dihydropyridine derivative. This unique agent stands out for its effectiveness as an organ circulation disorder improving agent or a peripheral circulation improving agent. This breakthrough holds promise for enhancing the quality of life for individuals affected by various circulatory issues.
Career Highlights
Minori Okita is currently affiliated with The Green Cross Corporation, where she continues to push the boundaries of innovation in healthcare. Her work has not only garnered attention for its scientific merit but also for its potential practical applications in treating circulatory disorders.
Collaborations
Throughout her career, Okita has collaborated with esteemed colleagues such as Hiroshi Shinyama and Toru Kawamura. These partnerships have allowed her to share ideas and enhance the development of her innovative projects, contributing to a collaborative environment that fosters creativity and scientific advancement.
Conclusion
Minori Okita exemplifies the spirit of innovation in medical science. Her dedicated work in developing effective circulatory disorder treatments highlights the impact inventors can have on improving health outcomes. As she continues her journey at The Green Cross Corporation, the medical community eagerly anticipates her future contributions to the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
